Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Assessment and grading of cancer chemotherapy-induced neuropathic pain
Judith A. Paice
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Assessment and grading of cancer chemotherapy-induced neuropathic pain'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Chemotherapy
100%
Chemotherapy-induced Peripheral Neuropathy
100%
Chemotherapy-induced Neuropathic Pain
100%
Diabetes
25%
Chemotherapy
25%
Risk Factors
25%
Early Detection
25%
Patient Report
25%
Comorbidity
25%
Adverse Effects
25%
Oncologists
25%
Patient Experience
25%
Early Change
25%
Effective Prevention
25%
Alcoholism
25%
Laboratory Values
25%
Aggregate Data
25%
Early Management
25%
Pain Syndrome
25%
Grading Scale
25%
Medicine and Dentistry
Cancer Chemotherapy
100%
Chemotherapy-Induced Peripheral Neuropathy
100%
Neuropathic Pain
100%
Diabetes
25%
Patient Experience
25%
Alcoholic Polyneuropathy
25%
Oncologist
25%
Adverse Effect
25%
Comorbidity
25%
Nursing and Health Professions
Cancer Chemotherapy
100%
Neuropathic Pain
100%
Chemotherapy-Induced Peripheral Neuropathy
100%
Oncologist
25%
Laboratory Value
25%
Comorbidity
25%
Neuroscience
Neuropathic Pain
100%
Neuropathy
100%
Adverse Effect
25%
Comorbidity
25%